Literature DB >> 2529453

Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages.

M B Schapiro1, J S Luxenberg, J A Kaye, J V Haxby, R P Friedland, S I Rapoport.   

Abstract

Quantitative CT demonstrated increased CSF and 3rd ventricular volumes, and decreased gray matter and white matter volume, in older (greater than 45 years) Down's syndrome (DS) adults with dementia as compared with younger DS adults. Serial CT studies repeated after periods of up to 2 years demonstrated significant progressive cerebral atrophy. Older DS adults without dementia, but with cognitive decline, did not show cerebral atrophy as compared with young DS subjects. These results suggest brain atrophy must be present to accompany dementia in older DS subjects, despite the presence of Alzheimer's disease neuropathology in all older subjects. The Alzheimer's disease process in DS may occur in 2 stages, the 1st with neuropathology and cognitive decline, the 2nd with additional cerebral atrophy and dementia.

Entities:  

Mesh:

Year:  1989        PMID: 2529453     DOI: 10.1212/wnl.39.10.1349

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Protocols to establish genotype-phenotype correlations in Down syndrome.

Authors:  C J Epstein; J R Korenberg; G Annerén; S E Antonarakis; S Aymé; E Courchesne; L B Epstein; A Fowler; Y Groner; J L Huret
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

2.  DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Authors:  Xiao-Yan Tang; Lei Xu; Jingshen Wang; Yuan Hong; Yuanyuan Wang; Qian Zhu; Da Wang; Xin-Yue Zhang; Chun-Yue Liu; Kai-Heng Fang; Xiao Han; Shihua Wang; Xin Wang; Min Xu; Anita Bhattacharyya; Xing Guo; Mingyan Lin; Yan Liu
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

3.  Down's syndrome and the links with Alzheimer's disease.

Authors:  A J Holland; C Oliver
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

4.  Overexpressed Down Syndrome Cell Adhesion Molecule (DSCAM) Deregulates P21-Activated Kinase (PAK) Activity in an In Vitro Neuronal Model of Down Syndrome: Consequences on Cell Process Formation and Extension.

Authors:  Ramón Pérez-Núñez; Natalia Barraza; Arlek Gonzalez-Jamett; Ana Maria Cárdenas; Jean-Vianney Barnier; Pablo Caviedes
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

5.  Whole-brain voxel-based morphometry study of children and adolescents with Down syndrome.

Authors:  Filippo Carducci; Paolo Onorati; Claudia Condoluci; Giancarlo Di Gennaro; Pier Paolo Quarato; Alberto Pierallini; Marco Sarà; Silvia Miano; Riccardo Cornia; Giorgio Albertini
Journal:  Funct Neurol       Date:  2013 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.